See analyst estimates and all valuation multiples for Pharmacies
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $159B | 0.4x | 10.6x | |
| $38.4B | 0.3x | 10.4x | |
| $27.9B | 8.8x | 35.2x | |
| $8.6B | 2.1x | 35.5x | |
| $8.2B | 1.0x | 19.6x | |
| $7.6B | 1.0x | 12.5x | |
| $7.4B | 0.2x | 3.5x | |
| $6.2B | 0.9x | 9.3x | |
| $5.8B | 0.5x | 10.1x | |
| $4.8B | 1.8x | 14.2x | |
| $4.4B | 1.2x | 11.7x | |
| $4.4B | 0.6x | 10.9x | |
| $4.1B | 1.6x | 9.6x | |
| $3.7B | 0.4x | 8.9x | |
| $3.7B | 0.6x | 9.1x | |
| $3.4B | 0.6x | 8.8x | |
| $3.4B | 0.6x | 8.0x | |
| $3.3B | 0.2x | 4.6x | |
| $2.9B | 0.8x | 7.8x | |
| $2.6B | 1.0x | 58.1x | |
| $2.5B | 0.8x | 8.2x | |
| $2.5B | 0.8x | 10.1x | |
| $2.4B | 1.3x | 9.8x | |
| $2.3B | 0.4x | 4.9x | |
| $1.8B | 2.3x | 6.8x | |
| $1.7B | 0.8x | 9.7x | |
| $1.5B | 1.3x | 10.7x | |
| $1.2B | 0.4x | 5.7x | |
| $1.2B | 1.6x | 20.7x | |
| $1.1B | 0.4x | n/a | |
| $1.1B | n/a | n/a | |
| $1.0B | 0.4x | 4.8x | |
| $968M | n/a | n/a | |
| $955M | 0.4x | 6.4x | |
| $907M | n/a | n/a | |
| $769M | 0.6x | n/a | |
| $747M | 1.4x | 16.0x | |
| $631M | n/a | n/a | |
| $601M | n/a | n/a | |
| $549M | n/a | n/a | |
| $532M | 0.4x | -11.8x | |
| $322M | n/a | n/a | |
| $313M | 0.1x | 31.1x | |
| $282M | n/a | n/a | |
| $182M | 0.5x | 7.6x | |
| $158M | 0.1x | 5.0x | |
| $106M | n/a | n/a | |
| $93.7M | n/a | n/a | |
| $67.2M | n/a | n/a | |
| $31.2M | n/a | n/a | |
| $24.8M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharmacies